Comparison of the Immunogenicity of Wockhardt's Insulin Analogue Lispro and Lispro Mix With Eli Lilly's Insulin Analogue Humalog and Humalog Mix in Type 1 Diabetic Patients

Trial Profile

Comparison of the Immunogenicity of Wockhardt's Insulin Analogue Lispro and Lispro Mix With Eli Lilly's Insulin Analogue Humalog and Humalog Mix in Type 1 Diabetic Patients

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 24 Jan 2013

At a glance

  • Drugs Insulin lispro (Primary) ; Insulin neutral protamine lispro/insulin lispro
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Wockhardt
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 24 Jan 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 23 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top